These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25662039)

  • 1. No effects of atorvastatin (10 mg/d or 80 mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study.
    Tsikas D; Pham VV; Suchy MT; van de Ree MA; Huisman MV; Frölich JC; Princen HM;
    Pharmacol Res; 2015 Apr; 94():1-8. PubMed ID: 25662039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results, meta-analysis and a first evaluation of U
    Tsikas D; Hanff E; Bollenbach A; Kruger R; Pham VV; Chobanyan-Jürgens K; Wedekind D; Arndt T; Jörns A; Berbée JFP; Princen HMG; Lücke T; Mariotti F; Huneau JF; Ückert S; Frölich JC; Lenzen S
    Amino Acids; 2018 Jul; 50(7):799-821. PubMed ID: 29728915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The L-arginine/NO pathway, homoarginine, and nitrite-dependent renal carbonic anhydrase activity in young people with type 1 diabetes mellitus.
    Carmann C; Lilienthal E; Weigt-Usinger K; Schmidt-Choudhury A; Hörster I; Kayacelebi AA; Beckmann B; Chobanyan-Jürgens K; Tsikas D; Lücke T
    Amino Acids; 2015 Sep; 47(9):1865-74. PubMed ID: 26123986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications.
    Hishinuma T; Tsukamoto H; Suzuki K; Mizugaki M
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):191-6. PubMed ID: 11728171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
    Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic oral L-arginine administration on the L-arginine/NO pathway in patients with peripheral arterial occlusive disease or coronary artery disease: L-Arginine prevents renal loss of nitrite, the major NO reservoir.
    Schneider JY; Rothmann S; Schröder F; Langen J; Lücke T; Mariotti F; Huneau JF; Frölich JC; Tsikas D
    Amino Acids; 2015 Sep; 47(9):1961-74. PubMed ID: 26123989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of paracetamol on NOS, COX, and CYP activity and on oxidative stress in healthy male subjects, rat hepatocytes, and recombinant NOS.
    Trettin A; Böhmer A; Suchy MT; Probst I; Staerk U; Stichtenoth DO; Frölich JC; Tsikas D
    Oxid Med Cell Longev; 2014; 2014():212576. PubMed ID: 24799980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease.
    Stichtenoth DO; Kreutzer FJ; Gutzki FM; Tsikas D; Nowak V; Frölich JC
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):211-4. PubMed ID: 11728174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A relationship between insulin resistance and reduction in oxidative stress in vivo by atorvastatin].
    Hitsumoto T; Iizuka T; Takahashi M; Nakamura K; Shimizu K; Satoh S; Sugiyama Y; Sakurai T; Noike H; Ohsawa H; Watanabe H; Shirai K
    J Cardiol; 2004 Dec; 44(6):233-42. PubMed ID: 15638221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
    Davì G; Ciabattoni G; Consoli A; Mezzetti A; Falco A; Santarone S; Pennese E; Vitacolonna E; Bucciarelli T; Costantini F; Capani F; Patrono C
    Circulation; 1999 Jan; 99(2):224-9. PubMed ID: 9892587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
    Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
    Scand J Clin Lab Invest; 2014 Jan; 74(1):8-19. PubMed ID: 24256611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin enhanced nitric oxide release and reduced blood pressure, nitroxidative stress and rantes levels in hypertensive rats with diabetes.
    Mason RP; Corbalan JJ; Jacob RF; Dawoud H; Malinski T
    J Physiol Pharmacol; 2015 Feb; 66(1):65-72. PubMed ID: 25716966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prostacyclin and thromboxane production in man during cardiopulmonary bypass.
    Ylikorkala O; Saarela E; Viinikka L
    J Thorac Cardiovasc Surg; 1981 Aug; 82(2):245-7. PubMed ID: 7019583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of urinary 8-epi-prostaglandin F2 alpha during cyclo-oxygenase inhibition in rats but not in man.
    Bachi A; Brambilla R; Fanelli R; Bianchi R; Zuccato E; Chiabrando C
    Br J Pharmacol; 1997 Aug; 121(8):1770-4. PubMed ID: 9283716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus.
    Su Y; Xu Y; Sun YM; Li J; Liu XM; Li YB; Liu GD; Bi S
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):21-5. PubMed ID: 19786892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
    Schwedhelm E; Bartling A; Lenzen H; Tsikas D; Maas R; Brümmer J; Gutzki FM; Berger J; Frölich JC; Böger RH
    Circulation; 2004 Feb; 109(7):843-8. PubMed ID: 14757688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population.
    Helmersson J; Vessby B; Larsson A; Basu S
    Circulation; 2004 Apr; 109(14):1729-34. PubMed ID: 15037525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins.
    Santilli F; Bucciarelli L; Noto D; Cefalù AB; Davì V; Ferrante E; Pettinella C; Averna MR; Ciabattoni G; Davì G
    Free Radic Biol Med; 2007 Nov; 43(9):1255-62. PubMed ID: 17893038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of prostanoids and nitric oxide by infarcted heart in situ and the effect of aspirin.
    Yamamoto T; Cohen AM; Kakar NR; Yamamoto M; Johnson PE; Cho YK; Bing RJ
    Biochem Biophys Res Commun; 1999 Apr; 257(2):488-93. PubMed ID: 10198239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.